Purpose
The objective ofthis field test instruction is to provide technical guidance for aqueous injection emplacement of an extension apatite permeable reactive barrier (PRE) for the sequestration of strontium-90 (Sr-90) using a high concentration amendment formulation. These field activities will be conducted according to the guidelines established in DOEIRL-2010-29, 1 OO-NR-2 Design Optimization Study, hereafter referred to as the DOS. The DOS supports the Federal Facility Agreement Consent Order (EPA et aI., 1989) , Milestone M-16-06-0I, and "Complete Construction of a Permeable Reactive Barrier at 100-N." Injections of apatite precursor chemicals will occur at an equal distance intervals on each end ofthe existing PRE to extend the PRB from the existing 91 m (300 ft) to at least 274 m (900 ft).
Objectives
The objectives ofthis injection of apatite precursor chemicals are to: 
Summary
Field testing at the 100-N Area Apatite Treatability Test Site, as depicted on Figure I , shows that the barrier is categorized by two general hydrologic conceptual models based on overall well capacity and contrast between the Hanford and Ringold hydraulic conductivities. The upstream portion ofthe original barrier, shown on Figure I , is characterized by relatively low overall well specific capacity. This is estimated from well development data and a lower contrast in hydraulic conductivity between the Hanford formation and Ringold Formations. Comparison oftest results from these two locations indicate that permeability contrast between the Hanford formation and Ringold Formation is significantly less over the upstream one-third ofthe barrier. The estimated hydraulic conductivity for the Hanford formation and Ringold Formation over the upstream portion ofthe barrier based on observations during emplacement ofthe existing 91 m (300 ft) PRE is approximately 12 and 10 m/day (39 and 32 ftlday), respectively (PNNL-17429). However, these estimates should be used as a rough guideline only, as significant variability in hydraulic conductivity is likely to be observed in the barrier extension wells, particularly those in the Ringold formation.
Existing Apa:ite Barrier Figure 3 • Exisr:ng Well 5 Aq uiler Tube Figure 1 , is characterized by generally higher well specific capacity and a larger hydraulic conductivity contrast between the Hanford formation and Ringold Formation. Hydraulic conductivity rates for the Hanford formation and Ringold Formation over the downstream portion of the barrier were estimated at 29 and 9 m/day (95 and 29 ftlday), respectively (with the Hanford formation hydraulic conductivity being greater in the downstream portion than the upstream portion). Once again, it should be noted that the actual conductivities may vary significantly, and the values state above should only be used as a rough initial estimates. Optimum apatite emplacement has been shown to occur when injections targeting the Hanford formation and the Ringold Formation are performed separately.
The remainder of this test instruction provides details for conducting these formation-targeted injections.
Injection Specification
Injection wells were constructed using 15.24 cm (6-in.) diameter polyvinyl chloride (PVC) screen and casing, and are completed at a depth of approximately 4.6 m (15 ft) below ground surface (bgs) for the shallow multi-purpose wells (Hanford formation) and 7.6 m (25 ft) bgs for the deep multi-purpose wells (Ringold Formation). 
Figure 2. Well Locations Upstream of Existing Permeable Reactive Barrier
Based on chemical arrival responses observed during previous barrier treatment operations and injection design analysis conducted to date, an injection volume between 227,000 liters (L) (60,000 gallons) and 454,000 L (120,000 gallons) of high concentration calcium-citrate-phosphate solution will be used for each well. This volume of amendment is calculated to provide sufficient volume to meet injection design criteria at the targeted radial extent of 6.1 m (20 ft).
Based on injection well hydraulic performance observed during previous barrier treatment operations, an initial injection rate of76 Llminute (20 gallons per minute [gpm]) is specified for treatment of the Hanford formation-and Ringold Formation-specific multipurpose wells both upstream and downstream of the existing barrier. At these flow rates, injection of the full 454,250 L (120,000-gallon) maximum target volume at each multi-purpose well will take approximately 100 hours to complete. The injection rate can be adjusted (within the range of76 to 190 Llminute [20 to 50 gpm]) based on hydraulic performance observed during injection. Because of the time required to inject each well, optimizing injection rates to the upper end of the injection range is desired to minimize the amount of time required to emplace the apatite solution over the full barrier length. Optimization of injection rates will be done in the field under the direction of the project lead.
During treatment at each well location, aqueous monitoring will be performed in adjacent injection wells and available monitoring wells, as specified below. In addition, pressure buildup during treatment will be monitored as described in Section 6. The wellhead shall be routinely evaluated for any evidence that a seal has been compromised. 
Figure 3. Well Locations Downstream of Existing Permeable Reactive Barrier
Based on the chemical delivery specification provided below, 16 tanker trucks will be required to deliver the required chemicals for each 12-well set of injections (8 truckloads of Ca-citrate solution, 8 truckloads of phosphate solution). These concentrated solutions will be subjected to a 12:1 dilution onsite to achieve the desired injection concentration. This dilution will be done using adjustable frequency drive pumps to adjust the ratio of makeup water and feed solutions. Injection will continue until the entire target injection volume has been injected into each of the targeted test wells.
Chemical Formulation
Solution composition, chemical delivery, and solubility concerns are described in the sections below.
Solution Composition
Laboratory and field treatability tests conducted to date found the most favorable formulation for field-scale deployment of high concentration calcium-citrate-phosphate formulation is a solution consisting of3.6 mM calcium, 9 mM citrate, and 40 mM phosphate. This is the specified solution to be used for the work covered under these test instructions. The formula for the high concentration apatite injection solution used in previous treatability tests is as follows: Also called diammonium phosphate.
Granular is more soluble than powdered. Reagent grade (quality) or equivalent: certified ACS, ACS registry 7783-28-0.
Other chemical formulations and mixing methods may be used as long as the resulting injection concentrations are the same.
Chemical Delivery Specification
The chemicals will be delivered to the site at the following concentrations:
• Each chemical feed solution (Mix I and Mix 2) will be diluted 12:1 with Columbia River water prior to injection to achieve the injection concentrations specified in Section 3.1.
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Timing and Order of Treatment
The initial barrier expansion milestone is to expand the PRB by a minimum of 91.4 m (300 ft) on either side ofthe existing apatite barrier, resulting in a total barrier length of274 m (900 ft). Additional wells adjacent to the proposed extent ofthe barrier expansion may be added to utilize full capacity ofthe injection skids. Barrier emplacement will be accomplished via the use of the two injection skids that can each inject six wells simultaneously. One skid will be placed on either end ofthe existing barrier so that barrier expansion on both the upstream and downstream ends ofthe existing barrier can be conducted simultaneously. Barrier expansion to 91.4 m (approximately 30 ft) on either side ofthe existing barrier will occur in multiple phases. Each of the treatment phases, which will be separated by a minimum 2-week reaction period, will consist oftreatment at 6 to 12 locations per injection cycle, depending on whether one or two injection skids are used (Table I) . Minimize impacts from adjacent injection operations, as listed in Table 1 , along with relative injection flow rates, and injection volume for each treatment. The order oftreatment was developed so that all Ringold Formation-targeted wells (deep multipurpose wells) will be treated together and all Hanford formation-targeted wells (shallow multipurpose wells) will be treated together. Injections 1 through 4 target the Ringold Formation and will begin in fall 2010 after finalization ofthe DOS. Injections 5 through 8 target the Hanford formation and are anticipated to begin in spring 2011.
Materials and Equipment
The minimum requirements for equipment and materials and additional sampling related materials and equipment are listed below:
• Power supply 
Test Monitoring
The chemical delivery system (skid) will be monitored on a regular basis to ensure appropriate flow rates are maintained. Measurements of system readings (flow rate and pressure) will be made on an hourly basis and field parameters (SpC, temperature, pH, and ORP) will be measured every 4 hours. An example record sheet is included as Appendix A.
• Samples will be collected from the injection stream at the start ofthe test (once rates have stabilized) and approximately every 12 hours thereafter (five samples total over the injection duration).
Aqueous samples will be collected and submitted for ion chromatography (IC) for anions and inductively coupled plasma(ICP) for major cations analysis.
Formation pressure will be maintained at a level where the packers remain sealed in the wells. Minimal pressure differential should exist between the injection well and the injection skid, so pressure monitoring will be conducted at the skid. Routine visual inspection ofthe injection well surface seal will be performed throughout the test to minimize solution ponding ifthe well seal is compromised.
Determination of apatite solution arrival/distribution during the injection test will be done through aqueous monitoring.
• All specified monitoring wells (as indicated in Table 2 ) will be monitored for field parameters (SpC, temperature, pH, ORP, and DO) once every 4 hours. Aquifer tube sampling is not required during this phase oftesting.
• Aqueous samples will be collected from specified monitoring wells and aquifer tubes immediately prior to injection start and once prior to the end ofthe injection (within approximately 6 hours). One sample of river water will be collected prior to mixing with the chemicals.
Aqueous samples will be collected and submitted for IC (anions) and ICP (major cations) analysis.
Primary performance monitoring will be through the collection of aqueous samples from monitoring wells and aquifer tubes as outlined in Table 2 .
• Field parameters (SpC, temperature, pH, ORP, and DO) will be measured for each sample collected.
• Samples will be collected from specified wells/aquifer tubes daily for the first week, every other day for the second week, and then weekly for the first month following injection.
• Aqueous samples will be submitted for the following analysis:
IC -anions ICP -major cations/metals Gross Beta Sr-90
• Depending on results of performance monitoring, core samples may be collected to determine apatite content and Sr-90 concentrations in sediment. 
Sampling and Analysis
Water will be pumped from the wells at a rate of 1 to 4 L1minute, using a peristaltic pump. Based on previous experience at the site, approximately 2 to 5 minutes of purge time should be sufficient time for parameter stabilization.
Once field parameters (pH, SpC, DO, ORP, and temperature) have stabilized, indicating that representative groundwater samples can be collected, parameter values will be recorded manually on data sheets provided by the lOO-N science technical lead. The original data sheets shall be provided to the lOO-N science technical lead to be placed into a bound (CH2M HILL Plateau Remediation Company [CHPRC] controlled) field notebook maintained for the Apatite PRE project at the earliest convenience following the test. Calibration offield probes is performed quarterly by CHPRC instrument technicians. Only equipment that is in calibration shall be used to perform field measurements. Field personnel using this equipment will check the equipment against National Institute of Standards and Technology (NIST) traceable standards once a day at a minimum. Results ofthese checks must be documented on forms provided by and returned to the lOO-N science technical lead. A final performance check is done at the conclusion ofthe injection test sampling. Calibration solutions will be provided by CHPRC. All field instrument check form originals shall also be returned to the lOO-N science technical lead for placement in the project field notebook.
The sample stream will be discharged to a purge water containment tank(s). Routine purge water collection and disposal will be required throughout these planned field activities. Sample collection and analysis for the planned apatite injections will be performed according to the guidelines set forth in Tables 3 through 5 . This test instruction applies to samples collected during injection and for the first month following treatment.
During injections, aquifer tubes (as outlined in Table 2 ) will be sampled and monitored for Sr-90, calcium, and phosphate, as described in Tables 3 and 5 . Aquifer tube samples are collected in accordance with the requirements for the Apatite PRE project sampling protocols.
If groundwater and aquifer tube monitoring data show that the flux of Sr-90 has been significantly reduced as a result of apatite barrier expansion, continuous soil cores will be collected. If no considerable reduction in Sr-90 flux is seen, soil cores will not be collected. Collection of soil cores will be performed by collecting continuous core samples from ground surface to total depth (7.6 m [25 ft D. These cores will be submitted for analysis of parameters as outlined in Table 3 . Sediment-core depths for Sr-90 and phosphate analysis will be at 0.6 to 0.9 m (2 to 3 ft) intervals to provide a vertical profile in each core of these constituents. A minimum of one random sample per core will be evaluated by electron microbe for identification of mineral phase apatite. during injection, well see Table 4 Apatite 
Sampling Locations
Specified monitoring locations (see Table 2 ) and one river make-up water sample.
Injection stream.
Specified monitoring locations (see Table 2 ).
Specified monitoring locations (see Table 2 ). a. Accuracy criteria for associated batch matrix spike percent recoveries. Evaluation based on statistical control of laboratory control samples is also performed. Precision criteria for batch laboratory replicate matrix spike analyses or replicate sample analyses.
b. This method has no quantitative requirements beyond adherence to the field measurement methodology.
Data Management
All operational, monitoring, and field parameter probe field standards check data will be recorded manually on data sheets which will be provided by the 100-N science technical lead for distribution to CHPRC personnel. The original data sheets will be placed into a bound (CHPRC controlled) field notebook by the 100-N science technical lead at the earliest convenience following the test. All samples submitted to analytical laboratories will be accompanied by an appropriately filled out chain of custody form.
Health and Safety
All work performed on site will be conducted in accordance with the Soil and Groundwater Remediation Project Site Specific Health and Safety Plan (HASP) (Fluor Hanford, 2008) and any applicable task specific Job Safety Analysis (CHPRC developed documents). Gloves and eye protection are needed while handling chemicals and during sample collection. A portable eye wash station will be present on site during injections. Sampling vehicles and or equipment includes hand-held portable eyewashes. All waste sampling materials (tubing, gloves, wipes, used filters, etc.), including any materials used to clean up spills or drops of sample media/injection fluid will be absorbed on wipes or other absorbent material and disposed of as waste in accordance with DOE/RL-2000-41, Interim Action Waste Management Planfor the IOO-NR-2 Operable Unit.
Residuals Management
All regulated waste generated during this injection activity, including sampling activities, will be managed in accordance with DOE/RL-2000-41, Interim Action Waste Management Plan for the
